The Role of a Clinical Pharmacist in Lifestyle Modification in Type 2 Diabetic Patients With Peripheral Neuropathy
NCT ID: NCT03356041
Last Updated: 2017-11-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2017-12-20
2018-03-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group
The intervention group will receive the three months' lifestyle modification program by a clinical pharmacist.
Diabetic patients with neuropathy
Lifestyle modification will be assessed using summary of diabetes self-care activity
Usual care Group
The usual care group will be provided the standard medical services
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diabetic patients with neuropathy
Lifestyle modification will be assessed using summary of diabetes self-care activity
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Both sex.
3. Diagnosed with type 2 diabetes at least one year previously.
4. Took at least one prescribed medication for diabetes.
5. Diagnosed as diabetic peripheral neuropathy based on clinical
Exclusion Criteria
2. Thyroid gland disorder.
3. Any kidney disorder.
4. Any conditions that could confound assessment of pain due to diabetic peripheral neuropathy.
5. Have foot injury or open sore.
6. Pregnant females or who plan to become pregnant during the study period.
7. Any serious medical condition that might prevent completion or hinder compliance with exercise.
\-
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hawler Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kawa Dizaye
Professor of Pharmacology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Prof. Kawa Dizaye
Erbil, , Iraq
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Kawa Dizaye, PhD
Role: primary
Anfal Al-Mallah, MSc
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Hawler Med University
Identifier Type: -
Identifier Source: org_study_id